EVOKE WEALTH, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
EVOKE WEALTH, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$8,000
+100.0%
3000.0%0.00%
Q2 2022$4,000
+100.0%
300
+160.9%
0.00%
Q4 2021$2,000
-33.3%
1150.0%0.00%
Q3 2021$3,0000.0%1150.0%0.00%
Q2 2021$3,0000.0%1150.0%0.00%
Q1 2021$3,0000.0%1150.0%0.00%
Q4 2020$3,0000.0%1150.0%0.00%
Q3 2020$3,0000.0%1150.0%0.00%
Q2 2020$3,000
-100.0%
115
-73.0%
0.00%
-100.0%
Q4 2019$6,914,000
+24.8%
4260.0%0.00%0.0%
Q3 2019$5,538,0004260.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$121,230,00021.92%
Rhenman & Partners Asset Management AB 220,000$5,808,0000.83%
ArrowMark Colorado Holdings LLC 2,045,862$54,011,0000.67%
Vivo Capital, LLC 77,373$2,043,0000.52%
Ghost Tree Capital, LLC 89,295$2,357,0000.49%
ESSEX INVESTMENT MANAGEMENT CO LLC 124,932$3,298,0000.47%
Polar Capital LLP 1,296,371$34,220,0000.46%
SUFFOLK CAPITAL MANAGEMENT LLC 70,095$1,851,0000.24%
EAM Investors, LLC 33,897$895,0000.15%
PointState Capital LP 438,200$11,568,0000.13%
View complete list of REVANCE THERAPEUTICS INC shareholders